Cart

Using Revere's proprietary MedTech (Medical Device) database which tracks the pipeline of every U.S. traded MedTech company, Revere analysts are able to continuously monitor the regulatory status of all device candidates. The result of this unmatched tracking capability is the MedTech PMA Pipeline Monitor Report, which provides one of the most comprehensive and accurate event calendars for expected FDA approval dates for PMA (Premarket Approval) filed Class III devices. In particular, this report identifies MedTech companies with expected PMA approvals in 2006 and 2007. Furthermore, the report also provides detail on each device candidate's (1) Tradenames and Indications, (2) Competitive Landscape, (3) Average Analyst Estimates, (4) Potential Market Size and (5) Approval Impact Ranking. Original, unbiased, insightful and actionable, the MedTech PMA Pipeline Monitor Report is an indispensable tool for successful MedTech investing.